Alexa Fluor® 488 anti-mouse Ly-6C Antibody
- 产品名称：
- Alexa Fluor® 488 anti-mouse Ly-6C Antibody
- 产品类别：
- 抗体
- 产品编号：
- 128021
- 产品应用：
- 128021
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- L3 cloned CTL cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Alexa Fluor? 488 under optimal conditions.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
* Alexa Fluor? 488 has a maximum emission of 519 nm when it is excited at 488 nm.
Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.
View full statement regarding label licenses - Excitation Laser
- Blue Laser (488 nm)
- Application Notes
Clone HK1.4 does not block the binding of clone RB6-8C58.
Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.
- Application References
(PubMed link indicates BioLegend citation) -
- Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
- Herold KC, et al. 1990. Diabetes 39:815. (Activ)
- Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
- Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
- Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
- Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
- Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
- Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
- Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
- Product Citations
-
- Baratchart E, et al. 2022. PLoS Comput Biol. 18:e1009839. PubMed
- Liu J, et al. 2019. Immunity. 50:600. PubMed
- Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
- Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
- Alexander J, et al. 2012. Kidney Int. 82:961. PubMed
- Vaibhav K, et al. 2018. J Exp Med. 215:2636. PubMed
- Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
- Guo P, et al. 2021. J Immunol. 207:408. PubMed
- Zenker S, et al. 2014. J Immunol. 192:2830. PubMed
- Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
- Kren N, et al. 2020. Sci Rep. 10:7390. PubMed
- Dang MT, et al. 2021. Cell Reports. 34(13):108917. PubMed
- Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
- Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
- Toomey CB, et al. 2018. Invest Ophthalmol Vis Sci. 59:662. PubMed
- Toomey C, et al. 2015. Proc Natl Acad Sci U S A. 112:3040. PubMed
- Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
- Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
- Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
- Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
- Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
- Lo CH, et al. 2021. Sci Rep. 6055:11. PubMed
- Breznik JA, et al. 2021. The Journal of Physiology. 599(8):2169-2195. PubMed
- Breznik JA, et al. 2021. Immunohorizons. 5:370. PubMed
- Yousef H, et al. 2019. Nat Med. 25:988. PubMed
- Skokowa J, et al. 2022. Nat Commun. 13:2948. PubMed
- Galuppo P, et al. 2017. FASEB J. . 10.1096/fj.201700317R. PubMed
- Kelley WJ, et al. 2022. JCI Insight. :. PubMed
- Maier N, et al. 2014. J Immunol. 192:763. PubMed
- Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
- Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
- Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
- Smith R, et al. 2016. J Leukoc Biol. 100:371-80. PubMed
- Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
- Winter C, et al. 2018. Cell Metab. 28:175. PubMed
- Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
- Ehrens A, et al. 2021. Cell Reports. 34(2):108621. PubMed
- Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
- Song W, et al. 2022. Immunity. 55:290. PubMed
- Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
- Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
- RRID
- AB_10640820 (BioLegend Cat. No. 128021) AB_10639728 (BioLegend Cat. No. 128022)
- Structure
- 14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
- Distribution
-
Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.
- Cell Type
- Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
- Biology Area
- Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.
- Gene ID
- 17067 View all products for this Gene ID
- UniProt
- View information about Ly-6C on UniProt.org
